![]() |
Volumn 23, Issue 5, 2002, Pages 254-260
|
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMOXICILLIN PLUS CLAVULANIC ACID;
BETA LACTAMASE;
CEFTAZIDIME;
CEPHALOSPORIN DERIVATIVE;
COTRIMOXAZOLE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
AMPICILLIN;
ANTIINFECTIVE AGENT;
CEFEPIME;
GENTAMICIN;
SULBACTAM;
SULTAMICILLIN;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIAL COLONIZATION;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
BACTERIUM ISOLATION;
CLINICAL ARTICLE;
CLONE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISEASE TRANSMISSION;
DRUG UTILIZATION;
ESCHERICHIA COLI;
FEMALE;
HOSPITALIZATION;
HUMAN;
INFECTION CONTROL;
KLEBSIELLA OXYTOCA;
LENGTH OF STAY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PREVALENCE;
RISK FACTOR;
CASE CONTROL STUDY;
COMMUNITY HOSPITAL;
CROSS INFECTION;
DRUG COMBINATION;
DRUG USE;
ENTEROBACTER INFECTION;
FECES;
HETEROZYGOTE;
HOSPITAL;
METHODOLOGY;
MICROBIOLOGY;
MIDDLE AGED;
PUBLICATION;
STANDARD;
STATISTICS;
UNITED STATES;
UNIVERSITY HOSPITAL;
ACADEMIC MEDICAL CENTERS;
ADULT;
AGED;
AGED, 80 AND OVER;
AMPICILLIN;
ANTIBIOTICS;
ANTIBIOTICS, AMINOGLYCOSIDE;
ANTIBIOTICS, COMBINED;
BETA-LACTAM RESISTANCE;
CARRIER STATE;
CASE-CONTROL STUDIES;
CEPHALOSPORINS;
CROSS INFECTION;
DRUG UTILIZATION REVIEW;
ESCHERICHIA COLI INFECTIONS;
FECES;
FEMALE;
FORMULARIES, HOSPITAL;
GENTAMICINS;
HOSPITALS, COMMUNITY;
HOSPITALS, URBAN;
HUMAN;
INFECTION CONTROL;
KLEBSIELLA INFECTIONS;
LENGTH OF STAY;
MALE;
MIDDLE AGE;
PENNSYLVANIA;
PREVALENCE;
RISK FACTORS;
SULBACTAM;
ANTI-BACTERIAL AGENTS;
DRUG THERAPY, COMBINATION;
HUMANS;
MIDDLE AGED;
|
EID: 0035999816
PISSN: 0899823X
EISSN: None
Source Type: Journal
DOI: 10.1086/502045 Document Type: Article |
Times cited : (77)
|
References (30)
|